Lefamulin最初由Nabriva开发,2018年3月仑胜医药获得在大中华区,包括中国大陆、香港、澳门、台湾开...查看全文
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2017-09-20 AccNo: 0001047469-17-005985 Size: 769 KB 网页链接
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 8-K - Current report Filed: 2017-09-20 AccNo: 0001104659-17-058089 Size: 378 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2017-09-20 AccNo: 0001047469-17-005985 Size: 769 KB 网页链接
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2017-09-19 AccNo: 0001047469-17-005934 Size: 769 KB 网页链接
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 内部交易: 2017-09-18,10% Owner,Vivo Capital VIII, LLC ,买入,52631普通股, $9.46
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 8-K - Current report Filed: 2017-09-18 AccNo: 0001104659-17-057510 Size: 3 MBItem 7.01: Regulation FD DisclosureItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 8-K - Current report Filed: 2017-09-15 AccNo: 0001104659-17-057404 Size: 54 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain...
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 内部交易: 2017-09-14,10% Owner,HBM Healthcare Investments (Ca ,卖出,3429普通股, $8.52
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 内部交易: 2017-09-13,10% Owner,HBM Healthcare Investments (Ca ,卖出,22721普通股, $8.54
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 内部交易: 2017-09-12,10% Owner,HBM Healthcare Investments (Ca ,卖出,10458普通股, $8.63